Notes from the North: April 2020

In response to news that an anti-viral drug (remdesivir) is showing promise in fast-tracked Phase III trials with COVID-19 patients, the market is ending a strong week on a strong note. This doesn’t change everything, but an effective treatment option would be a blessing, indeed, while we wait for more robust testing capabilities and a vaccine.

The Federal Reserve’s colossal interventions in recent weeks, the focus of this month’s comments, are already old news. It’s a whirlwind.

224 Main Street / P.O. Box 7 New London, NH 03257
Phone: 603-526-7400 / 800-526-4860 / Fax: 603-526-4842 /

46 South Main Street Concord, NH 03301
Phone: 603-228-5471 / Fax: 603-228-5478
info@tceainc.com

About Us

© 2020 Taylor, Cottrill, Erickson & Associates All Rights Reserved.